Last 7 days
-1.7%
Last 30 days
-15.8%
Last 90 days
14.6%
Trailing 12 Months
-21.2%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MSFT | 2.1T | 204.1B | 11.55% | -7.07% | 30.98 | 10.24 | 10.38% | -5.25% |
ORCL | 237.2B | 46.1B | 1.96% | 8.47% | 26.96 | 5.15 | 11.29% | -14.28% |
CRM | 189.5B | 31.4B | 16.34% | -11.18% | 911.01 | 6.04 | 19.41% | -85.60% |
ADBE | 173.2B | 17.6B | 7.52% | -13.23% | 36.42 | 9.84 | 11.54% | -1.37% |
ZM | 20.4B | 4.4B | -5.93% | -41.37% | 196.74 | 4.64 | 7.15% | -92.46% |
AZPN | 12.1B | - | -7.60% | 30.28% | 44.35 | 17.39 | - | - |
MID-CAP | ||||||||
PLAN | 9.6B | 631.5M | -1.97% | 16.85% | -45.68 | 15.19 | 33.30% | -26.60% |
MANH | 9.2B | 767.1M | 3.22% | 4.63% | 71.04 | 11.94 | 15.59% | 16.73% |
GWRE | 6.4B | 869.9M | 7.80% | -18.19% | -32.37 | 7.38 | 13.87% | -103.37% |
APPN | 2.9B | 468.0M | -7.97% | -36.63% | -19.31 | 6.23 | 26.74% | -70.26% |
PING | 2.4B | 308.3M | 1.17% | 7.67% | -23.16 | 7.93 | 13.75% | -237.98% |
SMALL-CAP | ||||||||
ZUO | 1.2B | 383.7M | 7.01% | -39.43% | -9.85 | 3.22 | 14.43% | -50.89% |
YEXT | 1.1B | 399.9M | 31.21% | 29.01% | -13.97 | 2.84 | 4.73% | 8.15% |
UPLD | 136.0M | 317.3M | -51.83% | -75.83% | -1.99 | 0.43 | 5.06% | -17.52% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 17.5% | 855,354,000 | 728,081,000 | 635,870,000 | 575,317,000 | 536,135,000 |
Gross Profit | 17.9% | 737,570,000 | 625,558,000 | 549,875,000 | 506,164,000 | 480,382,000 |
Operating Expenses | 13.8% | 1,038,081,000 | 911,941,000 | 817,891,000 | 713,357,000 | 616,647,000 |
S&GA Expenses | 11.3% | 541,673,000 | 486,664,000 | 433,722,000 | 378,183,000 | 334,480,000 |
R&D Expenses | 11.4% | 221,453,000 | 198,805,000 | 177,459,000 | 151,248,000 | 132,420,000 |
EBITDA | 1.4% | -266,693,000 | -270,609,000 | -253,615,000 | -189,861,000 | -121,943,000 |
EBITDA Margin | 16.1% | -0.31 | -0.37 | -0.40 | -0.33 | -0.23 |
Earnings Before Taxes | 1.9% | -313,778,000 | -319,871,000 | -304,481,000 | -241,947,000 | -177,531,000 |
EBT Margin | 16.5% | -0.37 | -0.44 | -0.48 | -0.42 | -0.33 |
Interest Expenses | -43.7% | 9,741,000 | 17,293,000 | 24,812,000 | 32,000,000 | 39,208,000 |
Net Income | 1.8% | -318,499,000 | -324,392,000 | -307,918,000 | -244,592,000 | -179,681,000 |
Net Income Margin | 16.4% | -0.37 | -0.45 | -0.48 | -0.43 | -0.34 |
Free Cahsflow | -29.1% | -128,480,000 | -99,558,000 | -43,242,000 | 9,583,000 | 30,391,000 |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 9.4% | 1,557 | 1,424 | 1,456 | 1,477 | 1,600 |
Current Assets | 19.3% | 747 | 626 | 633 | 622 | 933 |
Cash Equivalents | 19.4% | 105 | 88.00 | 111 | 147 | 152 |
Net PPE | -8.9% | 69.00 | 76.00 | 75.00 | 72.00 | 71.00 |
Goodwill | 0.1% | 398 | 398 | 400 | 399 | 57.00 |
Liabilities | 9.1% | 1,384 | 1,268 | 1,285 | 1,246 | 1,197 |
Current Liabilities | 31.0% | 512 | 391 | 403 | 363 | 409 |
Shareholder's Equity | 11.2% | 174 | 156 | 172 | 231 | 403 |
Retained Earnings | -7.7% | -443 | -411 | -336 | -230 | -190 |
Additional Paid-In Capital | 9.6% | 622 | 568 | 512 | 466 | 599 |
Accumulated Depreciation | - | 25.00 | - | - | - | - |
Shares Outstanding | 0.5% | 69.00 | 68.00 | 68.00 | - | - |
Cashflow (Last 12 Months) | (In Thousands) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -41.9% | -104,847 | -73,908 | -7,989 | 46,009 | 63,159 |
Share Based Compensation | 11.6% | 226,518 | 202,937 | 174,960 | 144,788 | 124,065 |
Cashflow From Investing | 669.4% | 96,700 | 12,569 | -137,300 | -135,482 | -66,885 |
Cashflow From Financing | -10.6% | -35,222 | -31,855 | -24,227 | -15,632 | -14,075 |
99.6%
69.6%
60.4%
Y-axis is the maximum loss one would have experienced if Alteryx was unfortunately bought at previous high price.
9.8%
-18.3%
FIve years rolling returns for Alteryx.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -43.45 | -318,565 | 335,435 | -% |
2023-03-10 | BAILLIE GIFFORD & CO | unchanged | - | -1,975 | 17,025 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -38.03 | -20,000 | 26,000 | -% |
2023-03-02 | LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | new | - | 25,336 | 25,336 | -% |
2023-02-28 | Voya Investment Management LLC | added | 2.1 | -5,532,900 | 69,732,100 | 0.10% |
2023-02-27 | Parallax Volatility Advisers, L.P. | added | 33.3 | 351,293 | 2,026,290 | -% |
2023-02-24 | NATIXIS | reduced | -42.54 | -7,792,700 | 8,485,300 | 0.05% |
2023-02-24 | SRS Capital Advisors, Inc. | sold off | -100 | -38,000 | - | -% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | sold off | -100 | -2,000 | - | -% |
2023-02-21 | MACQUARIE GROUP LTD | sold off | -100 | -144,000 | - | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 13, 2023 | capital world investors | 7.8% | 4,783,159 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.17% | 5,615,095 | SC 13G/A | |
Feb 07, 2023 | blackrock inc. | 7.0% | 4,285,909 | SC 13G | |
Feb 06, 2023 | stoecker dean | 11.15% | 7,720,751 | SC 13G/A | |
Feb 24, 2022 | blackrock inc. | 4.97% | 2,963,356 | SC 13G/A | |
Feb 14, 2022 | coatue management llc | 0% | 0 | SC 13G/A | |
Feb 14, 2022 | bares capital management, inc. | 7.92% | 4,729,876 | SC 13G/A | |
Feb 14, 2022 | brown capital management llc | 2.77% | 1,652,121 | SC 13G/A | |
Feb 11, 2022 | capital research global investors | 0.0% | 0 | SC 13G/A | |
Feb 11, 2022 | capital world investors | 12.2% | 7,311,447 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 2.30 -95.92% | 6.67 -88.17% | 18.45 -67.28% | 45.60 -19.13% | 83.52 48.11% |
Current Inflation | 3.24 -94.25% | 4.26 -92.45% | 8.67 -84.62% | 18.92 -66.45% | 39.55 -29.86% |
Very High Inflation | 1.80 -96.81% | 4.97 -91.19% | 13.01 -76.93% | 31.44 -44.25% | 56.78 0.69% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 10, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 06, 2023 | 8-K | Current Report | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-08 | Schloss Eileen | sold | -294,615 | 65.47 | -4,500 | - |
2023-03-07 | RUBIN KEVIN | acquired | - | - | 43,726 | chief financial officer |
2023-03-07 | Anderson Mark | acquired | - | - | 115,068 | chief executive officer |
2023-03-07 | Vittal Suresh | acquired | - | - | 43,726 | chief product officer |
2023-03-07 | Lal Christopher M | acquired | - | - | 23,013 | clo & corp. secretary |
2023-03-07 | Natali Chris | acquired | - | - | 11,506 | chief accounting officer |
2023-03-07 | Hansen Paula | acquired | - | - | 51,780 | president & cro |
2023-03-01 | RUBIN KEVIN | sold (taxes) | -706,587 | 65.34 | -10,814 | chief financial officer |
2023-03-01 | Lal Christopher M | sold (taxes) | -309,712 | 65.34 | -4,740 | clo & corp. secretary |
2023-03-01 | Hansen Paula | sold (taxes) | -232,741 | 65.34 | -3,562 | president & cro |
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Revenue: | ||||
Total revenue | $ 215,712 | $ 123,501 | $ 554,276 | $ 362,330 |
Cost of revenue: | ||||
Total cost of revenue | 31,994 | 15,466 | 86,007 | 39,237 |
Gross profit | 183,718 | 108,035 | 468,269 | 323,093 |
Operating expenses: | ||||
Research and development | 54,803 | 33,457 | 162,030 | 95,645 |
Sales and marketing | 135,976 | 83,034 | 384,781 | 232,597 |
General and administrative | 56,887 | 37,125 | 172,777 | 104,291 |
Impairment of long-lived assets | 0 | 0 | 8,239 | 0 |
Total operating expenses | 247,666 | 153,616 | 727,827 | 432,533 |
Loss from operations | (63,948) | (45,581) | (259,558) | (109,440) |
Interest expense | (2,454) | (9,973) | (7,291) | (29,206) |
Other expense, net | (6,905) | (2,363) | (15,698) | (1,561) |
Loss before provision for income taxes | (73,307) | (57,917) | (282,547) | (140,207) |
Provision for income taxes | 1,206 | 122 | 4,299 | 1,928 |
Net loss | $ (74,513) | $ (58,039) | $ (286,846) | $ (142,135) |
Net loss per share attributable to common stockholders, basic (in dollars per share) | $ (1.09) | $ (0.86) | $ (4.20) | $ (2.12) |
Net loss per share attributable to common stockholders, diluted (in dollars per share) | $ (1.09) | $ (0.86) | $ (4.20) | $ (2.12) |
Weighted-average shares used to compute net loss per share attributable to common stockholders, basic (in shares) | 68,673 | 67,325 | 68,273 | 67,109 |
Weighted-average shares used to compute net loss per share attributable to common stockholders, diluted (in shares) | 68,673 | 67,325 | 68,273 | 67,109 |
Other comprehensive income (loss), net of tax: | ||||
Net unrealized holding loss on investments, net of tax | $ (393) | $ (61) | $ (3,395) | $ (1,619) |
Foreign currency translation adjustments | 3,971 | 769 | 8,668 | (133) |
Other comprehensive income (loss), net of tax | 3,578 | 708 | 5,273 | (1,752) |
Total comprehensive loss | (70,935) | (57,331) | (281,573) | (143,887) |
Subscription-based software license | ||||
Revenue: | ||||
Total revenue | 111,590 | 37,477 | 255,416 | 120,851 |
Cost of revenue: | ||||
Total cost of revenue | 2,940 | 1,264 | 7,984 | 3,739 |
PCS and services | ||||
Revenue: | ||||
Total revenue | 104,122 | 86,024 | 298,860 | 241,479 |
Cost of revenue: | ||||
Total cost of revenue | $ 29,054 | $ 14,202 | $ 78,023 | $ 35,498 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 87,729 | $ 152,375 |
Short-term investments | 292,178 | 506,874 |
Accounts receivable, net | 110,490 | 192,318 |
Prepaid expenses and other current assets | 136,025 | 81,360 |
Total current assets | 626,422 | 932,927 |
Property and equipment, net | 75,887 | 71,270 |
Operating lease right-of-use assets | 83,426 | 102,681 |
Long-term investments | 59,414 | 343,213 |
Goodwill | 397,720 | 57,415 |
Intangible assets, net | 64,064 | 21,737 |
Other assets | 117,095 | 70,445 |
Total assets | 1,424,028 | 1,599,688 |
Current liabilities: | ||
Accounts payable | 25,126 | 8,086 |
Accrued payroll and payroll related liabilities | 47,355 | 61,391 |
Accrued expenses and other current liabilities | 51,515 | 53,917 |
Deferred revenue | 182,784 | 208,154 |
Convertible senior notes, net | 84,463 | 77,400 |
Total current liabilities | 391,243 | 408,948 |
Convertible senior notes, net | 792,188 | 686,016 |
Operating lease liabilities | 65,612 | 78,784 |
Other liabilities | 18,836 | 23,186 |
Total liabilities | 1,267,879 | 1,196,934 |
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value: 10,000 shares authorized as of September 30, 2022 and December 31, 2021, respectively; no shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively | 0 | 0 |
Common stock, $0.0001 par value: 500,000 Class A shares authorized, 61,171 and 59,771 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively; 500,000 Class B shares authorized, 7,739 and 7,763 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively | 7 | 7 |
Additional paid-in capital | 567,909 | 598,710 |
Accumulated deficit | (411,506) | (190,429) |
Accumulated other comprehensive loss | (261) | (5,534) |
Total stockholders’ equity | 156,149 | 402,754 |
Total liabilities and stockholders’ equity | $ 1,424,028 | $ 1,599,688 |